FDA NDC Directory · JSON-LD · Markdown

DYANAVEL XR

NDC 24478-110 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic nameamphetamine
Labeler / ManufacturerNextWave Pharmaceuticals, Inc
Marketing categoryNew Drug Application (innovator) · App NDA210526
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsAMPHETAMINE (20 mg/1)
Marketing started20211104
Package count1

External sources

Source: openFDA. Public-domain (CC0).